SCHEMBL1848440

SCHEMBL1848440

O=C1Cc2cccc(Br)c2C[N]1

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.38
PIM1 P11309 1/20 0.37
CSNK1A1 P48729 1/20 0.37
CDK5 Q00535 1/20 0.37
ROCK1 Q13464 1/20 0.37
DYRK1A Q13627 1/20 0.37
LRRK2 Q5S007 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
PARP10 Q53GL7 1/20 0.35
PARP11 Q9NR21 1/20 0.35
ABHD6 Q9BV23 4/20 0.33
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5780088 0.78 MEN1 (0.44)
SCHEMBL2327414 0.72 CYP1A2 (0.52) TRPA1PIM1CSNK1A1CDK5ROCK1
SCHEMBL29907208 0.72 CYP1A2 (0.52) TRPA1PIM1CSNK1A1CDK5ROCK1
SCHEMBL2490656 0.71 CYP1A2 (0.50) CYP1A2
SCHEMBL585448 0.70 TRPA1 (0.40) TRPA1PIM1CSNK1A1CDK5ROCK1
SCHEMBL1662187 0.69 CYP2A6 (0.52) TRPA1PIM1CSNK1A1CDK5ROCK1
SCHEMBL29385577 0.69 CYP2A6 (0.52) TRPA1PIM1CSNK1A1CDK5ROCK1
SCHEMBL17132727 0.67 TRPA1 (0.49) TRPA1PIM1CSNK1A1CDK5ROCK1
SCHEMBL7913165 0.67 CYP2A6 (0.44) TRPA1PIM1CSNK1A1CDK5ROCK1
SCHEMBL1948839 0.67 CDK5 (0.53) TRPA1PIM1CSNK1A1CDK5ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323482-A1 SUBSTITUTED DIHYDROISOQUINOLINONE AND ISOQUINOLINEDIONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Merck & Co., Inc. (US) 2011-05-25 EP disclosed
WO-2010017048-A1 SUBSTITUTED DIHYDROISOQUINOLINONE AND ISOQUINOLINEDIONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2010-02-11 WO disclosed